Maximum quantity allowed is 999
Please select the quantity
CAS RN: 69975-86-6 | Product Number: D4302
Doxofylline
Purity: >98.0%(T)(HPLC)
Synonyms:
- 7-(1,3-Dioxolan-2-ylmethyl)theophylline
- 7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethyl-1H-purine-2,6-dione
- 7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethylxanthine
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Shipping Information |
---|---|---|---|---|---|
1G |
$94.00
|
13 | 3 | Contact Us | |
25G |
$284.00
|
13 | 0 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Product Number | D4302 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__1H__1__4N__4O__4 = 266.26 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 69975-86-6 |
Reaxys Registry Number | 561195 |
PubChem Substance ID | 253659730 |
Merck Index (14) | 3438 |
MDL Number | MFCD00865218 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 142.0 to 146.0 °C |
Properties (reference)
Melting Point | 144 °C |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
RTECS# | XH5135000 |
Transport Information:
H.S.code* | 2934.99-000 |
Application
Studies of the Mechanism of Action of Doxofylline
References
- Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects
- The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism
Application
Analyses of Doxofylline in Serum
References
- Non-extraction HPLC method for simultaneous measurement of dyphylline and doxofylline in serum
- F. Tagliaro, R. Dorizzi, A. Frigerio, M. Marigo, Clin. Chem. 1990, 36, 113.
- Development and validation of a stability-indicating RP-HPLC method for analysis of doxofylline in human serum. Application of the method to a pharmacokinetic study
- R. Gannu, S. Bandari, S. G. Sudke, Y. M. Rao, B. P. Shankar, Acta Chromatogr. 2007, 19, 149.
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.